Stock Alert: CureVac Declines 7%; Prices Public Offering

By RTTNews Staff Writer   ✉   | Published:

Shares of biopharmaceutical company CureVac N.V. (CVAC) are falling more than 7% Thursday morning at $87.70.

The company today priced the follow-on public offering of 5 million common shares at $90.00 per share for total gross proceeds of about $450 million.

The offering is expected to close on February 1, 2021.

CVAC has been trading in the range of $36.15- $151.8 in the last one year.

For comments and feedback contact: editorial@rttnews.com

Business News

Previous Story
Next Story
Editors Pick
Commerzbank To Cut About 10,000 Jobs By 2024
Commerzbank (CRZBY.PK) said Thursday that it will reduce about 10,000 jobs by 2024. It will also reduce branches to 450 locations across Germany from the current level of 790, as part of its restructuring. Costs will be reduced by 1.4 billion euros or around 20 per cent by 2024, while revenues are expected to remain stable.
Apple's New Privacy Rules Soon
Amidst uproar about data privacy issues involving Facebook and Google, Apple is taking a step in helping users take control of their personal data and protecting them from data tracking. In June, Apple had announced certain updates to iOS 14 that, among other changes, required apps to ask users for permission to collect and share data using Apple's device identifier.
McDonald's Q4 Profit Down; U.S. Comps. Up 5.5%
McDonald's Corp. (MCD) Thursday reported a profit for the fourth-quarter that declined 12 percent from last year, reflecting sales declines in the International Operated Markets and International Developmental Licensed Markets segments as a result of COVID-19 resurgences and government restrictions. Quarterly revenues decreased 2 percent. Global comparable sales declined 1.3 percent.